IN8bio, Inc. (INAB)

IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $19.10 million. The enterprise value is -$5.70 million.

Market Cap	19.10M
Enterprise Value	-5.70M

Important Dates

The last earnings date was Thursday, March 12, 2026, after market close.

Earnings Date	Mar 12, 2026
Ex-Dividend Date	n/a

Share Statistics

IN8bio has 9.85 million shares outstanding. The number of shares has increased by 145.08% in one year.

Current Share Class	9.85M
Shares Outstanding	9.85M
Shares Change (YoY)	+145.08%
Shares Change (QoQ)	+56.50%
Owned by Insiders (%)	11.53%
Owned by Institutions (%)	25.18%
Float	6.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.67
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.82, with a Debt / Equity ratio of 0.10.

Current Ratio	8.82
Quick Ratio	8.57
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -92.49% and return on invested capital (ROIC) is -49.80%.

Return on Equity (ROE)	-92.49%
Return on Assets (ROA)	-46.64%
Return on Invested Capital (ROIC)	-49.80%
Return on Capital Employed (ROCE)	-68.20%
Weighted Average Cost of Capital (WACC)	3.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.14M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.01% in the last 52 weeks. The beta is 0.00, so IN8bio's price volatility has been lower than the market average.

Beta (5Y)	0.00
52-Week Price Change	-74.01%
50-Day Moving Average	2.00
200-Day Moving Average	2.14
Relative Strength Index (RSI)	54.24
Average Volume (20 Days)	36,690

Short Selling Information

The latest short interest is 138,633, so 1.41% of the outstanding shares have been sold short.

Short Interest	138,633
Short Previous Month	146,831
Short % of Shares Out	1.41%
Short % of Float	2.00%
Short Ratio (days to cover)	3.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.86M
Pretax Income	-19.44M
Net Income	-19.44M
EBITDA	-18.09M
EBIT	-19.86M
Earnings Per Share (EPS)	-$4.44

Balance Sheet

The company has $27.09 million in cash and $2.78 million in debt, with a net cash position of $24.31 million or $2.47 per share.

Cash & Cash Equivalents	27.09M
Total Debt	2.78M
Net Cash	24.31M
Net Cash Per Share	$2.47
Equity (Book Value)	27.56M
Book Value Per Share	2.82
Working Capital	24.72M

Cash Flow

Operating Cash Flow	-12.71M
Capital Expenditures	n/a
Free Cash Flow	-12.71M
FCF Per Share	-$1.29

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-145.08%
Shareholder Yield	-145.08%
Earnings Yield	-104.45%
FCF Yield	-68.30%

Analyst Forecast

The average price target for IN8bio is $6.00, which is 209.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	209.28%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-31.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 6, 2025. It was a reverse split with a ratio of 1:30.

Last Split Date	Jun 6, 2025
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	2